1Brownlee M,Cerami A,Vlassara H.Advanced glycosylation end products in tissue and the biochemic basis of diabetic complications. N Engl J Med,1988,318:1315.
2Makita Z,Vlassara H,Rayfield E et al.Hemoglobin-AGE:a circulating marker for advanced glycosylation, Science 1992,258:651.
4The DAMAD Study Group, Effect of aspirin along and aspirin plus dipyridamole in early diabetic retinopathy,a multicenter randomized controlled clinical trail.Diabetes1989,38:491.
5Mole DI,Safirstein RL,Mcervy RC et al.Effect of aspirin on experimental diabetic nephropathy,J Lab Clin Med,1987,110:300.
6Sensi M,Bruno MR,Pozzilli P. In vitro inhibition of non-enzymatic glycosylation induced by aspirin.Med Sic Res,1987,15:99.
3Bjorck S, Nyberg G, Mulec H, et al. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy[J]. BMJ, 1986. 293:471.
4Cotreras I, Rieser KM, Martinz N. et al. Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM[J]. Diabetes Care,1997,20:832.
